[1]袁瑛,顾兆祥.放射性核素显像在轻度认知功能障碍中的应用价值[J].国际放射医学核医学杂志,2008,32(4):209-213.
　YUAN Ying,GU Zhao-xiang.Applications of radionuclide imaging in mild cognitive impairment[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):209-213.
点击复制

放射性核素显像在轻度认知功能障碍中的应用价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第4期
页码:
209-213
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Applications of radionuclide imaging in mild cognitive impairment
作者:
袁瑛;  顾兆祥
200040 上海, 复旦大学附属华东医院核医学科
Author(s):
YUAN Ying;  GU Zhao-xiang
Department of Nuclear Medwine, Huadong Hospital, Fudan University, Shanghai 200040, China
关键词:
认知障碍; 阿尔茨海默病; 基因; 载脂蛋白E; 放射性核素显像
Keywords:
Cognition disorders; Ahheimer disease; Gene; apolipoprotein E; Radionuelide imaging
摘要:
轻度认知功能障碍(MCI)患者存在进展为痴呆的高度危险,早期发现将进展为阿尔茨海默病(AD)的MCI有重要的实验研究和临床意义。放射性核素显像已广泛应用于研究MCI脑代谢和脑血流量以及评价MCI的预后。综述了近年来放射性核素显像以及与载脂蛋白E基因型分析等其他方法联合使用对于MCI预后判断的价值。
Abstract:
The risk for conversion to dementia is much higher in individuals with mild eoghitived impairmaent (MCI).The early detection of MCI individuals who will later convert to Alzheimer disease is an important issue for both clinical and research interests.Radionuclide imaging has been broadly used to study cerebral membolism and blood flow,as well as predicting the prognosis of MCI.This review summarizes the results of these studies assessing the predicting value of radionuelide imaging used alone and with other methods in recent years.

参考文献/References:

[1] Petersen RC.Mild cognitive impairment as a diagnostic entity[J].J Intern Med,2004,256(3):183-194.
[2] Petersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive imparment[J].Arch Neurol,2001,58(12):1985-1992.
[3] Johnson KA,Moran EK Becker JA.et al.Single photon emission computed tomography perfusion differences in mild cognitive impairment[J].J Neural Neurosurg Psychiatry,2007,78(3):240-247.
[4] Hirao K Ohnishi T, Hirata Y,et al.The prediction of rapid conversion to Alzheimer’s disease in mild cognitive impairment using regional cerebral blood flow SPECT[J].Neuroimage,2005, 28(4):1014-1021.
[5] Ishiwata A,Sakayori O,Mineshima S.et al.Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment:a qualitative and quantitative SPECT study[J].Acta Neurol Scand,2006,114(2):91-96.
[6] 高平,秦绍森,蔡晓杰,等.Alzheimer病与轻度认知功能障碍的脑SPECT显像[J].中华核医学杂志,2006,26(4):213-215.
[7] Chételat G,Desgranges B,de la Sayette V,et al.Mild cognitive impairment:Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?[J].Neurology,2003,60(8):1374-1377.
[8] Pardo JV,Lee JT,Sheikh SA.et al.Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal agindfl.Neuroimage,2007,35(3):1231-1237.
[9] Mosconi L,De Santi S,Li J,et al.Hippocampal hypometabotism predicts cognitive decline from normal aging[J].Neurobiol Aging, 2008,29(5):676-692.
[10] Kropholler MA,Boellaard R,van Berckel BN,et al.Evaluation of reference regions for (R)-[(11)C] PKlll95 studies in Alzheimer’s disease and mild cognitive impairment[J].J Cereb Blood Flow Metab,2007,27(12):1965-1974.
[11] Hasselbalch SG,Madsen K,Svarer C.et al.Reduced 5-HT2A.receptor binding in patients with mild cognitive impairment[J]. Neurobiol Aging,2008,29(12):1830-1838.
[12] Huang C,Eidelberg D,Habeck C,et al.Imaging markers of mild cognitive impairment:multivariate analysis of CBF SPECT[J]. Neurobiol Aging,2007,28(7):1062-1069.
[13] Borroni B,Anchisi D,Paghera B.et al.Combined 90Tc-ECD SPECT and neurepsychological studies in MCI fur the assessment of conversion to AD[J].Neurobiol Aging,2006,27(1):24-31.
[14] 王荫华,陈晓红,汤哲,等.轻度认知功能障碍的神经心理学研究和ApoE基因多态性分析[J].中国康复理论与实践,2005,11(3):202-205.
[15] Mosconi L Herholz k Prohovnik I,et al.Metabolic interaction between ApoE genotype and onset age in Alzheimer’s disease: implications for brain reserve[J].J Neurol Neurosurg Psychiatry. 2005,76(1):15-23.
[16] Drzezga A,Grimmer T,Riemenschneider M,et al.Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET[J].J Nucl Med,2005,46(10):1625-1632.
[17] Mosconi L.Perani,D,Sorbi S,et al.MCl conversion to dementia and the APOE genotype:a prediction study with FDG-PET[J].Neurology,2004,63(12):2332-2340.
[18] Forsberg A,Engler H,Almkvist O,et al.PET imaging of amyloid deposition in pafients with mild cognitive impairment[J].Neurobiol Aging,2008.29(10):1456-1465.
[19] Fellgiebel A,Scheufieh A,Bartenstein P,et al.FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment[J].Psychiatry Res,2007,155(2):167-171.

相似文献/References:

[1]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
　Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[2]段小艺,李淼,王黎,等.阿尔茨海默病PET正电子药物应用与研究进展[J].国际放射医学核医学杂志,2014,38(5):318.[doi:10.3760/cma.j.issn.1673-4114.2014.05.010]
　Duan Xiao-yi,Li Miao,Wang Li,et al.Application and research progress of PET positron tracers associated with Alzheimer disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):318.[doi:10.3760/cma.j.issn.1673-4114.2014.05.010]
[3]王新艳,管一晖.阿尔茨海默病的影像学诊断进展[J].国际放射医学核医学杂志,2013,37(1):52.[doi:10.3760/cma.j.issn.1673-4114.2013.01.014]
　WANG Xin-yan,GUAN Yi-hui.The advancement in Alzheimer disease of imaging diagnosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):52.[doi:10.3760/cma.j.issn.1673-4114.2013.01.014]
[4]孔艳艳,管一晖,吴平.PET分子探针在阿尔茨海默病早期诊断中的研究进展[J].国际放射医学核医学杂志,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
　KONG Yan-yan,GUAN Yi-hui,WU Ping.Novel PET molecular probes for early diagnosis of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
[5]王颖,蔡莉,李彦生,等.11C-PIB PET在不同时期阿尔茨海默病中的研究进展[J].国际放射医学核医学杂志,2013,37(6):378.[doi:10.3760/cma.j.issn.1673-4114.2013.06.013]
　WANG Ying,CAI Li,LI Yan-sheng,et al.Application of 11C-PIB PET in different period of the Alzheimer disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):378.[doi:10.3760/cma.j.issn.1673-4114.2013.06.013]
[6]张冰,徐俊,徐运,等.fMRI在阿尔茨海默病、额颞叶痴呆及路易体痴呆中的研究进展[J].国际放射医学核医学杂志,2010,34(5):303.[doi:10.3760/cma.j.issn.1673-4114.2010.05.015]
　ZHANG Bing,XU Jun,XU Yun,et al.The study of fMRI in Alzheimer’s disease, frontotemporal dementia and Lewy bodies dementia[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):303.[doi:10.3760/cma.j.issn.1673-4114.2010.05.015]
[7]蔡莉,高硕.PET在精神分裂症中的研究进展[J].国际放射医学核医学杂志,2011,35(2):69.[doi:10.3760/cma.j.issn.1673-4114.2011.02.002]
　CAI Li,GAO Shuo.Progress of PET imaging in Schizophrenia[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):69.[doi:10.3760/cma.j.issn.1673-4114.2011.02.002]
[8]陈贵兵,吴华,彭添兴.正电子显像剂11C-匹兹堡化合物B的化学合成及其临床应用[J].国际放射医学核医学杂志,2008,32(3):158.
　CHEN Gui-bing,WU Hua,PENG Tian-xing.Chemical synthesis and clinical application of a new positron imaging agent 11C-Pittsburgh compound-B[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):158.
[9]郭喆,张锦明.阿尔茨海默病的放射性分子显像探针研究进展[J].国际放射医学核医学杂志,2006,30(4):199.
　GUO Zhe,ZHANG Jin-ming.Study on radioactive labeling of molecular probes for Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):199.
[10]蔡汉成,尹端沚,张岚,等.早期诊断阿尔茨海默病的PET分子探针[J].国际放射医学核医学杂志,2006,30(4):202.
　CAI Han-cheng,YIN Duan-zhi,ZHANG Lan,et al.PET molecular probes for early detection of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):202.
[11]李祖贵.轻度认知障碍的功能性神经影像学研究进展[J].国际放射医学核医学杂志,2006,30(2):76.
　LI Zu-gui.The progress of functional neuroimaging in the study of mild cognitive impairment[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):76.

备注/Memo

备注/Memo:
收稿日期:2007-11-22。
通讯作者:顾兆祥,E-mail:guzx2222@yahoo.com.cn
更新日期/Last Update: 1900-01-01